首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 109 毫秒
1.
中西医结合治疗甲状腺功能亢进症结果比较   总被引:2,自引:0,他引:2  
郭立仪 《中国现代医生》2008,46(15):174-175
目的探讨中西医结合治疗甲状腺功能亢进症疗效。方法甲亢患者80例随机分为治疗组(中西医结合治疗)40例和对照组(西医治疗)40例,两组均于开始时口服他巴唑15~30mg/d,用药减至维持量(2.5-5mg/d)时,治疗组加中药治疗,对照组单纯服抗甲状腺药物。服药后观察患者症状、体征,并复查血清T3、T4或FT3、FT4及TSH并进行两组疗效分析。结果两组治疗后较治疗前TT3、TT4、FT3、FT4含量下降(P〈0.05),S-TSH含量上升(P〈0.05);与对照组治疗后比较,治疗组TT3、FT3下降更为明显(P〈0.05)。治疗组痊愈率高于对照组(P〈0.05),无效率低于对照组(P〈0.05)。结论中西医结合治疗甲状腺功能亢进症疗效较对照组好。  相似文献   

2.
目的比较利培酮、阿立哌唑对女性精神分裂症甲状腺素水平的影响。方法对60例符合CCMD-Ⅲ及ICD-10诊断标准的精神分裂症患者随机分为利醅酮组和阿立哌唑组。用药范围:利醅酮起始剂量1mg/d~6mg/d,阿立哌唑起始剂量5mg/d~30mg/d。疗程均为8周,在治疗前后检测血清FT3、FT4、TSH水平,分别与健康对照组比较,采用PANSS、CGI、TESS评定精神症状、临床疗效及其他相关因素。结果利醅酮组FT3在治疗后明显下降,差异有统计学意义(p〈0.05)。阿立哌唑组FT3、FT4显著下降,差异有统计学意义(p〈0.01)。结论利醅酮、阿立哌唑均可使甲状腺素水平减低,阿立哌唑较利醅酮明显。  相似文献   

3.
目的:探讨甲状腺功能亢进症(甲亢)患者血浆生长激素释放肽(Ghrelin)水平的变化及其影响因素。方法:分别于治疗前后对43例甲亢患者(观察组)与43例健康人进行甲状腺激素、空腹血糖、血浆Ghrelin、身体成分检测,并进行对比分析,探讨甲亢患者血浆Ghrelin水平的变化及影响因素。结果:观察组与对照组年龄、身高比较,差异无统计学意义(P〉0.05);观察组治疗前体重、体质量指数(BMI)、体脂比例、血浆Ghrelin及超敏促甲状腺素(S—TSH)均低于对照组,而血清游离T3(FT3)、游离T4(FT4)、及空腹血糖(FPG)则高于对照组,差异具有统计学意义(P〈0.01或P〈0.05);观察组治疗后体重、体脂比例、BMI、Ghrelin以及S—TsH均增高,FT3、FT4及FPG降低,差异具有统计学意义(P〈0.0l或P〈0.05);血浆Ghrelin水平与体脂比例、S—TSH均呈显著正相关(r=0.26,P〈0.05;r=0.29,P〈0.01),与FT3、FT4均呈显著负相关(r=0.42,r=0.38,P〈0.01)。结论:甲亢患者血浆Ghrelin水平随甲亢病情变化而变化,与体脂比例、s—TSH呈正相关,与FT3、FT4呈负相关,对甲亢病情的评估及疗效的判定等均具有重要意义。  相似文献   

4.
目的 探讨慢性心力衰竭(CHF)患者甲状腺激素(TH)水平的变化规律及其临床意义。方法 采用化学发光免疫法测定109例CHF患者和32例对照组血清三碘甲状腺原氨酸(T3)、甲状腺素(T4)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)及促甲状腺素(TSH)的水平并比较。结果 ①CHF患者与对照组比较,血清T3、T4、FT3,均降低(P〈0.05或P〈0.01),FT4、TSH无明显变化(P〉0.05);②T3、T4、FT3,随心衰程度加重逐渐降低(P〈0.05或P〈0.01);③ TSH在心衰各亚组间比较差异无统计学意义(P〉0.05)。结论 慢性心力衰竭患者常伴有正常甲状腺功能病态综合征,其甲状腺激素水平的变化程度与心衰严重程度相关。  相似文献   

5.
刁殿琰 《吉林医学》2009,30(13):1235-1236
目的:探讨甲状腺机能亢进症治疗前后血清中TSH、FT3、FT4及SIL-2R水平变化的临床意义。方法:采用电化学发光法和ELISA分别测定TSH、FT3、FT4及SIL-2R水平,分析甲状腺机能亢进症患者治疗前后和对照组血清中TSH、FT3、FT4及SIL-2R水平变化情况。结果:观察组治疗前的TSH、FT3、FT4均明显高于对照组(P〈0.05),经临床治疗后观察组TSH、FT3、FT4水平明显降低(P〈0.05);甲状腺机能亢进症患者血清中SIL-2R水平非常显著地高于正常人组(P〈0.05),经治疗后明显降低,恢复正常(P〈0.05),SIL-2R水平与TSH、FT3、FT4相关性分析:血清中SIL-2R水平与TSH、FT3、FT4呈明显正相关(r1=0.672、r2=0.651、r3=0.662,P〈0.01)。结论:TSH、FT3、FT4及SIL-2R可以作为甲状腺机能亢进症患者临床诊治和观察预后的重要理论依据,可广泛应用。  相似文献   

6.
陈娟 《中国现代医生》2013,(15):75-76,78
目的探讨丙硫氧嘧啶联合氟羟强的松龙在治疗自身免疫性甲状腺疾病(AITD)伴甲亢患者的临床疗效。方法将2010年5月~2012年8月收集的70例AITD伴甲亢患者随机分为两组:丙硫氧嘧啶治疗组和丙硫氧嘧啶联合氟羟强的松龙治疗组。每组35例。在治疗过程中,同时监测两组患者的血清促甲状腺激素(TSH)、血清游离甲状腺素(FT4)、血清游离三碘甲状腺原氨酸(FT3)、血清甲状腺过氧化物酶抗体(TPOAb)和甲状腺球蛋白抗体(TGAb)的变化水平,并分析其治疗效果。结果丙硫氧嘧啶治疗组治疗后FT4下降明显(P〈0.05),TSH的水平略有上升,TPOAb和TGAb与治疗前相比差异无显著性(P〉0.05);丙硫氧嘧啶联合氟羟强的松龙治疗组治疗后FT3、FT4、TPOAb和TGAb较治疗前有下降明显,差异有统计学意义(P〈0.05),TSH较治疗前有显著性上升(P〈0.05)。结论丙硫氧嘧啶与氟羟强的松龙联合用药可以有效降低自身免疫性甲状腺疾病伴有甲亢患者血清中FT3、FT4、TPOAb和TGAb的水平,抑制病情的进一步发展,促进甲状腺功能的恢复。  相似文献   

7.
目的观察先天性甲状腺功能减退症(CH,甲低)儿童的肝功能改变,及与血清甲状腺激素(TH)水平的相关性,探讨TH对儿童肝功能的影响。方法对40例CH儿童和35例健康儿童进行肝脏彩超及肝功能检查,同时用化学发光法测定血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(TT4)、总三碘甲状腺原氨酸(TT3)、总甲状腺素(讯)和促甲状腺素(TSH)水平,对肝功能指标和血清TH水平进行相关性分析。结果与健康儿童组相比,CH组血清FT3、TT3、FT4、TT4水平显著下降,TSH水平显著升高(P〈0.001);CH组肝功能异常明湿高于健康组(P〈0.001),且肝功能异常与FT3、FT4、TT3、TT4呈显著负相关,与TSH呈显著正相关(P〈0.05),两组肝脏彩超检查无显著差异(P〉0.05),表明先天性甲状腺功能减退症会对患儿的肝功能造成一定的损伤。结论CH对儿童肝功能产生显著影响,临床医师应加强对此类疾病的重视。  相似文献   

8.
目的观察不同剂量甲巯咪唑治疗Graves病的临床疗效,研究治疗前后其雌激素水平变化。方法56例病例随机分为低剂量组(15mg/d,一次口服)和常规剂量组(30mg/d,分3次服),每组各28例。观察治疗治疗3个月后临床疗效及副反应,检测用药前及用药后3个月白血病计数、转氨酶(ALT、AST)水平、甲状腺激素(FT3、FT4)、促甲状腺激素释放激素(TSH)及雌激素(E,)水平,18—24月停药,随访2年复发率。结果治疗3个月后,两组临床疗效无显著性差异(P〉0.05),FT3、FT4、TSH及E,水平较治疗前显著性减低(P〈0.05),低剂量组副反应发生率较常规剂量组显著性减低(P〈0.05),两组随访复发率无差异fP〉0.05)。结论低剂量给药可以达到治疗Graves病的同时减低副反应发生率,雌激素与Graves病发生具有一定相关性。  相似文献   

9.
目的:探讨胎儿宫内发育迟缓(IUGR)孕妇血清和脐血甲状腺激素的变化。方法:采用放射免疫分析法测定正常足月妊娠孕妇62例(对照组)和IUGR孕妇24例(IUGR组)血清和脐血中甲状腺素(T4)、三碘甲状腺原氨酸(T3)、游离T3(FT3)、游离T4(FT4)、促甲状腺素(TSH)水平。结果:IUGR组孕妇血清和脐血中TSH高于对照组(P<0.05),脐血T4、FT4均明显下降(P<0.05),两组母血与脐血T3、T4、FT4、TSH均呈正相关(均P<0.05)。结论:IUGR发病原因与甲状腺激素水平低下有关,在妊娠期可以通过测定母血甲状腺功能,尽早对IUGR做出诊断,使IUGR在宫内得到及时,有效的治疗。  相似文献   

10.
谭丽玲 《中国热带医学》2011,11(4):499-500,510
目的通过检测患者血清中脑纳肽的含量来评价甲亢性心脏病左室功能受累情况。方法测定并比较甲亢心23例(甲亢心组),甲状腺功能亢进症19例(甲亢纽)以及对照纽14例的血清脑纳肽(BNP)、左室射血分数(LVEF),二尖瓣血流频谱E/A比值等指标,并以BNP为诊断指标,对甲亢心进行诊断试验评价。结果甲亢心组患者治疗前血清BNP水平均显著高于甲亢组(RO,01),LVEF及E/A比值明显低于甲亢组(P〈0.05),甲亢心组血清BNP水平与FT3、FT4水平呈显著正相关(r=0.801,P〈0.05;r=0.578,P〈0.05),与LVEF、E/A比值呈显著负相关(r=-0.48,P〈O.05,r=-0.35,P〈0.05)。甲亢心组和甲亢组患者治疗3个月后血清BNP、FT3、FF4显著低于治疗前(P〈0.05)。IJVEF、E/A比值显著高于治疗前(P〈O.05)。结论血清BNP检测是患者甲亢心比较快速、实用、无创、有效的诊断指标,其水平的高低结合LVEF、E/A比值可反映甲亢心的严重程度以及心肌损害的程度。  相似文献   

11.
Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P < 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (>0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P <0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P < 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.  相似文献   

12.
Objective: To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods: SD rats served as both donors and recipients. 4℃ sodium lactate Ringer's was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava (IVC) inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results: Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion: This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.  相似文献   

13.
Objective To observe blood pressure change with age in salt-sensitive teenagers whose salt sensitivity were determined by repeated testing.Methods Salt sensitivity was determined through intravenous infusion of normal saline combined with volume-depletion by oral diuretic furosemide in 55 teenagers. After five years, salt sensitivity was re-examined and subject blood pressure was followed up. Blood pressure changes in salt-sensitive teenagers were compared to that of non-salt sensitive teenagers over five years.Results After 5 years, the repetition rate of salt sensitivity determined by intravenous saline loading is 92.7%. In teenagers with salt sensitivity on the baseline, both the systolic blood pressure increments and increment rates were much higher than non-salt sensitive teenagers (12.7±12.1 mmHg vs. 2.8±5.2 mmHg, P< 0.01; 12.2%± 12.0% vs. 2.5% ±4.4%, P< 0.001,respectively). There was a similar trend for diastolic blood pressure (8.4 ± 6.4 mmHg vs. 3.7 ± 6.4 mmHg, P = 0.052; 13.2% ±10.6 % vs. 6.8%± 10.1%, P = 0.053, respectively).Conclusions Salt sensitivity determined by intravenous saline loading showed good reproducibility. Blood pressure increments with age were much higher in salt-sensitive teenagers than non-salt sensitive teenagers, especially in terms of systolic blood pressure.  相似文献   

14.
目的:评价使用安心颗粒对急诊经皮冠状动脉介入术(PPCI)术后生活质量的影响.方法:将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组(术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次)和对照组(仅接受基础药物治疗).所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表(MIDAS)、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果:入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异(P>0.05);出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低(P<0.05);组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低(P<0.05).两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血(P>0.05).两组发生轻度血小板减少症的患者数比较无差异(P>0.05).结论:PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.  相似文献   

15.
Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P<0.01);the MAP decreased(P<0.01)and the HR increased drastically(P<0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.  相似文献   

16.
Objective:To investigate the gene expression of osteoprotegerin(OPG) and osteoclast differentiation factor(ODF) in the bone tissue of patients with hip fracture due to osteoporosis. Methods:OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers(over 50 years old) with hip fracture(Observer Group) and 30 cases of hip facture sufferers with no osteoporosis(Control group) were analyzed with the Semi-Quantitative RT-PCR method. Results:The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion:Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.  相似文献   

17.
Objective:To investigate the clinical features, pathological characteristics and immunophenotype of solid-pseudopapillary tumor of the pancreas(SPTP). Methods:Nine surgically treated cases of SPTP were retrospectively reviewed. Hematoxylin and Eosin(HE) staining and immunohistochemical staining were used to analyze all cases, and the general clinical data was collected. Results:Six patients were asymptomatic except for a palpable mass. Two patients complained of vague-epigastric pain. One patient appeared jaundice. The tumor was encapsulated and solid tissues alternately with cystic tissues. Histologically, the histological structure of solid portion was pseudopapillary with a fibrovascular core. Tumor cells were uniform and medium-sized which were arranged in sheets ets or nests or pseudopapillary patterns. Immunohistochemical studies demonstrated that SPTP proved positive in vimentin(9/9 cases), AAT(9/9 cases), NSE(9/9 cases), ACT(7/9 cases), CK20(2/9 cases), CgA(1/9 cases), S-100(3/gcases), PR(4/gcases), Syn(3/9 cases) and CD56(5/9cases), negative in CEA and ER. Conclusion:SPTP is a tumor predominantly occurring in young women frequently without special symptoms. This tumor has various characteristical histological patterns with different immunophenotype.  相似文献   

18.
Objective:To probe into the influence of changes of ovarian hormones on the pathogenesis of the specific sub-type premenstrual syndrome(PMS)and reveal partial microcosmic mechanisms of adverse flow of liver-qi.Methods:Estradiol(E2)and progesterone(P)levels in serum were determined at different phases of menstrual cycle by radioimmunoassay.Results:In the group of PMS with adverse flow of liver-qi.the secretive peak value Of E2 and P at the follicular phase significantly decreased,and the secretive peak value at the luteal phase did not come into being.Conclusions:Low E2 and P secretive peak at the follicular phase and absence of secretive peak at the luteal phase is one of the microcosmic mechanisms of PMS with adverse flow of liver-qi.One of the pathophysiologic mechanisms of specific sub-type PMS is probably the continuous low level of E2and P.  相似文献   

19.
Real-time three-dimensional echocardiography (RT3DE)is a new ultrasound technique that enables dynamic threedimensional visualization and quantification of the heart in real time. Investigation of feasibility and methodology of RT3DE in determining left ventricular (LV) and right ventricular (RV) volumes, RT3DE was performed in 35 normal adults using Philips SONOS 7500 system with a 2-4 MHz matrix array transducer. The 60°×60° "pyramid" volume database was obtained and analyzed on a TomTec echo workstation. Both LV and RV volumes were calculated with four 3DE methods (i.e. apical 2, 4, 8, and 16-plane) through manually tracing ventricular endocardial borders in end diastole and end systole. Stroke volumes were then calculated. LV volume was also measured by 2DE Simpson's rule using GE VIVID 7 ultrasound machine.  相似文献   

20.
Increasing maternal age is the only etiological factor unequivocally linked to Down's syndrome in humans. The occurrence rate of newborns with Down's syndrome is about 1/220 in women over 35 years old. However, the occurrence rate in embryos fertilized in vitro, of the elder woman is unclear. Using FISH we screened the number of chromosome 21 in preimplanted embryos of 5 elderly women (average age, 38.4 years) to study the feasibility and necessity of screening trisomy 21 in embryos in patients over 35 years old at the in vitro fertilization (IVF) center.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号